Clariant to tap Indian pharma sector with packaging and anti-counterfeit solutions
The company, which is setting up a healthcare packaging production facility in Cuddalore, has launched technology to combat counterfeiting in medical devices and packaging Revised Outcome of Board Meeting
Clariant Chemicals (India) Ltd has informed BSE that the Board of Directors of the Company at its Revised meeting held on December 01, 2016, inter alia, has approved reappointment of Dr. Deepak Parikh as Vice Chairman and Managing Director ofthe Company for a period of 3 years from February 01, 2017 to January 31, 2020 subject to approval of the shareholders by way of a Special Resolution through Postal Ballot and all other applicable statutory... Results Press Release for September 30, 2016
Clariant Chemicals (India) Ltd has informed BSE about : 1. Result Press Release for the period ended September 30, 2016 Outcome of Board Meeting
Clariant Chemicals (India) Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 01, 2016, inter alia, has approved and taken on record the following;1. The Un-Audited Financial Results for the 2nd quarter and half year ended September 30, 2016 alongwith Statement of Abstract of Balance Sheet for the half year ended September 30, 2016.... Standalone Financial Results, Limited Review Report for September 30, 2016
Clariant Chemicals (India) Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Standalone Limited Review for the period ended September 30, 2016 Clariant & Sicpa launch brand protection technology for medical devices in India
Two companies have jointly developed Plastiward, an integrated protection for plastic pharmaceutical packaging and medical devices, for tackling counterfeit problem Board Meeting Intimation for Results & Closure of Trading Window
Clariant Chemicals (India) Ltd has informed BSE that a Meeting of Board of Directors of the Company will be held on December 01, 2016, inter alia, to consider and take on record the Un-Audited Financial Results for the 2nd quarter and half year ended September 30, 2016.In compliance with Code of Conduct framed by the Company for Prohibition of Insider Trading pursuant to the requirement of SEBI (Prohibition of Insider Trading) Regulations,... Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Clariant Chemicals (India) Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Clariant eyes to tap personal care market with new ingredients
The company's Metamorphosis by Plantasens solution, coupled with its new trend guide BeautyForward, will aid brand owners develop futuristic personal care products Shareholding for the Period Ended September 30, 2016
Clariant Chemicals (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here